The 31 linked references in paper V. Mishlanov Yu., В. Мишланов Ю. (2014) “ДЕФЕНЗИНЫ И ДРУГИЕ ПРОТИВОМИКРОБНЫЕ ПЕПТИДЫ: РОЛЬ НАРУШЕНИЙ БЕЛОКСИНТЕЗИРУЮЩЕЙ СПОСОБНОСТИ НЕЙТРОФИЛОВ В ПАТОГЕНЕЗЕ ЗАБОЛЕВАНИЙ ОРГАНОВ ДЫХАНИЯ // DEFENSINS AND OTHER ANTIMICROBIAL PEPTIDES AND A ROLE OF NEUTROPHIL PROTEIN-SYNTHESING FUNCTION DISORDERS FOR PATHOGENESIS OF RESPIRATORY DISEASES” / spz:neicon:pulmonology:y:2014:i:3:p:104-112

  1. Schibli D.J., Hunter H.N., Aseyev V. et al. The Solution Structures of the Human β-Defensins Lead to a Better Understanding of the Potent Bactericidal Activity of HBD3 against Staphylococcus aureus, JBC 2001; doi: 10.1074/jbc. M108830200.
  2. Augustin D.K., Heimer S.R., Tam C. et al. Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Infect. and Immun. 2011; 79 (2): 595–605. doi: 10.1128/IAI.00854-10.
  3. Zanger P., Holzer J., Schleucher R. et al. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human betadefensin 2. Infect. and Immun. 2010; 78 (7): 3112–3117. doi: 10.1128/IAI.00078-10.
  4. Tiszlavicz Z., Endresz V., Nemeth B. et al. Inducible expression of human β-defensin 2 by Chlamydophila pneumoniae in brain capillary endothelial cells. Innate Immun. 2011; 17 (5): 463–469. doi: 10.1177/1753425910375582.
  5. Абатуров А.Е.Катионные антимикробные пептиды системы неспецифической защиты респираторного тракта: дефензины и кателицидины. Дефензины – молекулы, переживающие ренессанс. Часть 4. Здоровье ребенка. 2012; 2 (37): 154–160. / Abaturov A.E. Cationic antimicrobial peptides of respiratory non-specific defense: defensins and catelicidin. Defensins as revirescent molecules. Part 4. Zdorov'e rebenka. 2012; 2 (37): 154–160 (in Russian).
  6. Kim S.K., Park S., Lee E.S.Toll-like receptors and antimicrobial peptides expressions of psoriasis: correlation with serum vitamin D level. J. Korean Med. Sci. 2010; 25 (10): 1506–1512. doi: 10.3346/jkms.2010.25.10.1506.
  7. Usui T., Yoshikawa T., Orita K. et al. Changes in salivary antimicrobial peptides, immunoglobulin A and cortisol after prolonged strenuous exercise. Eur. J. Appl. Physiol. 2011; 111 (9): 2005–2014. doi: 10.1007/s00421-011-1830-6.
  8. Gambichler T., Bechara F.G., Scola N. et al. Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters. Arch. Dermatol. Res. 2012; 304 (6): 471–474. doi: 10.1007/s00403-012-1227-3.
  9. Eyerich S., Wagener J., Wenzel V. et al. IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur. J. Immunol. 2011; 41 (7): 1894–1901. doi: 10.1002/eji.201041197.
  10. Guani-Guerra E., Negrete-Garcia M.C., Montes-Vizuet R. et al. Human β-defensin-2 induction in nasal mucosa after administration of bacterial lysates. Arch. Med. Res. 2011; 42 (3): 189–194. doi: 10.1016/j.arcmed.2011.04.003.
  11. Deng L.X., Wu G.X., Cao Y. et al. The chromosomal protein HMGN2 mediates the LPS-induced expression of β-defensins in mice. Inflammation / 2012; 35 (2): 456–473. doi: 10.1007/s10753-011-9335-3.
  12. Lan C.C., Wu C.S., Huang S.M. et al.High-glucose environment reduces human β-defensin-2 expression in human keratinocytes: implications for poor diabetic wound healing. Br. J. Dermatol. 2012; 166 (6): 1221–1229. doi: 10.1111/ j.1365-2133.2012.10847.x.
  13. Vahavihu K., Ala-Houhala M., Peric M. et al.Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br. J. Dermatol. 2010; 163 (2): 321–328. doi: 10.1111/j.1365-2133.2010.09767.x.
  14. 1): 64–69. doi: 10.1016/j.joen.2009.09.022. 36.Yoon Y.M., Lee J.Y., Yoo D. et al.Bacteroides fragilis enterotoxin induces human beta-defensin-2 expression in intestinal epithelial cells via a mitogen-activated protein kinase/I kappaB kinase/NF-kappaB-dependent pathway. Infect. end Immun. 2010; 78 (5): 2024–2033. doi: 10.1128/IAI.00118-10. (the paper at Socionet)
  15. Lee S.I., Min K.S., Bae W.J. et al. Role of SIRT1 in heat stress- and lipopolysaccharide-induced immune and defense gene expression in human dental pulp cells. J Endod 2011; 37(11): 1525–1530. doi: 10.1016/j.joen.2011.07.006.
  16. Scharf S., Zahlten J., Szymanski K. et al.Streptococcus pneumoniae induces human β-defensin-2 and -3 in human lung epithelium. Exp. Lung Res. 2012; 3 8 (2): 100–110. doi: 10.3109/01902148.2011.652802.
  17. Routsias J.G., Karagounis P., Parvulesku G. et al. In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains. Peptides. 2010; 31 (9): 1654–1660. doi: 10.1016/j.peptides.2010.06.010. Обзоры
  18. Tohidnezhad M., Varoga D., Wruck C.J. et al. Platelets display potent antimicrobial activity and release human betadefensin 2. Platelets. 2012; 23 (3): 217–223. doi: 10.3109/09537104.2011.610908.
  19. Pereira A.L., Holzhausen M., Franco G.C. et al.Human β-defensin 2 and protease activated receptor-2 expression in patients with chronic periodontitis. Arch. Oral. Biol. 2012; 57 (12): 1609–1614. doi: 10.1016/j.archoralbio.2012.04.018.
  20. Chang A.B., Yerkovich S.T., Gibson P.G. et al. Pulmonary innate immunity in children with protracted bacterial bronchitis. J. Pediatr. 2012; 161 (4): 621–615. e1.doi: 10.1016/j.jpeds.2012.03.049.
  21. Pace E., Giarratano A., Ferraro M. et al. TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure. Hum. Immunol. 2011; 72 (1): 54–62. doi: 10.1016/ j.humimm.2010.09.009.
  22. Liao Z., Dong J., Hu X. et al. Enhanced expression of human β-defensin 2 in peripheral lungs of patients with chronic obstructive pulmonary disease. Peptides. 2012; 38 (2): 350–356. doi: 10.1016/j.peptides.2012.09.013.
  23. Zhang W., Case S., Bowler R.P. et al. Cigarette smoke modulates PGE(2) and host defense against Moraxella catarrhalis infection in human airway epithelial cells. Respirology 2011; 16 (3): 508–516. doi: 10.1111/j.14401843.2010.01920.x.
  24. Mahanonda R., Sa-Ard-Iam N., Eksomtramate M. et al. Cigarette smoke extract modulates human beta-defensin-2 and interleukin-8 expression in human gingival epithelial cells. J. Periodontol. Res. 2009; 44 (4): 557–564. doi: 10.1111/j.1600-0765.2008.01153.x.
  25. Vordenbaumen S., Timm D., Bleck E. et al. Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener's granulomatosis. Rheumatol. Int. 2011; 31 (9): 1251–1254. doi: 10.1007/ s00296-010-1702-0.
  26. Gupta S., Ghosh S.K., Scott M.E. et al. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J. Biol. Chem. 2010; 285 (47): 36523–36531. doi: 10.1074/jbc. M110.133140.
  27. Hostanska K., Melzer J., Amon A., Saller R. Suppression of interleukin (IL)-8 and human beta defensin-2 secretion in LPS-and / or IL-1β-stimulated airway epithelial A549 cells by a herbal formulation against respiratory infections (BNO 1030). J. Ethnopharmacol. 2011; 134 (2): 228–233. doi: 10.1016/j.jep.2010.12.006.
  28. Shen Z., Lei H. Expression of hBD-2 induced by 23-valent pneumococcal polysaccharide vaccine, Haemophilus influenzae type b vaccine and split influenza virus vaccine. Mol. Med. Rep. 2012; 6 (4): 733–738. doi: 10.3892/ mmr.2012.1005.
  29. Marzani B., Pinto D., Minervini F. et al. The antimicrobial peptide pheromone Plantaricin A increases antioxidant defenses of human keratinocytes and modulates the expression of filaggrin, involucrin, β-defensin 2 and tumor necrosis factor-αgenes. Exp. Dermatol. 2012; 21 (9): 665–671. doi: 10.1111/j.1600-0625.2012.01538.x.
  30. Shao Z.J., Zheng X.W., Feng T. et al.Andrographolide exerted its antimicrobial effects by upregulation of human β-defensin-2 induced through p38 MAPK and NF-κB pathway in human lung epithelial cells. Can. J. Physiol. Pharmacol. 2012; 90 (5): 647–653. doi: 10.1139/y2012-050.
  31. Мишланов В.Ю. Барламов П.Н., Морозова Н.С.Липидвысвобождающая способность лейкоцитов и некоторые показатели иммунной недостаточности у больных внебольничной пневмонией. Медицинская иммунология. 2012; 6: 555–560. / Mishlanov V.Yu., Barlamov P.N., Morozova N.S. Leukocyte lipid-releasing properties and some parameters of immune insufficiency in patients with community-acquired pneumonia. Meditsinskaya immunologiya. 2012; 6: 555–560 (in Russian).